KMH-2 Cells

KMH-2 is a human anaplastic thyroid carcinoma (ATC) cell line derived from a male patient with a rapidly progressing and fatal form of thyroid cancer. Anaplastic thyroid carcinoma is one of the most aggressive and lethal thyroid malignancies, characterized by its rapid growth and resistance to conventional therapies. KMH-2 cells were established from a biopsy of the primary tumor before the patient underwent any chemotherapy or radiotherapy. These cells are highly relevant for studying the pathophysiology of ATC, as well as for testing the efficacy of new therapeutic agents.

The KMH-2 cell line exhibits a spindle-shaped morphology when cultured in vitro, which is typical of many anaplastic thyroid carcinoma cells. These cells have shown resistance to multiple chemotherapeutic agents, including cisplatin, doxorubicin, etoposide, and pepleomycin, reflecting the clinical challenge of treating ATC. The chemoresistance in KMH-2 cells has been attributed to the expression of multidrug resistance-associated protein (MRP) mRNA, although they do not express the mdr-1 and mdr-3 mRNAs associated with P-glycoprotein, suggesting that their drug resistance mechanism is independent of P-glycoprotein. This resistance to chemotherapy makes KMH-2 a valuable model for investigating alternative treatment strategies.

In terms of growth characteristics, KMH-2 cells have relatively long doubling times, and their tumorigenicity has been confirmed in xenotransplantation models using athymic nude mice. However, these cells required specific conditions to enhance proliferation in vivo, such as the use of a tiny plastic plate to facilitate growth post-inoculation. Chromosomal analysis of KMH-2 has revealed multiple abnormalities, a common feature in aggressive cancers, which further underscores their utility in studying the genetic underpinnings of anaplastic thyroid carcinoma.